MDXXF (Pharmala Biotech Holdings) EV-to-EBITDA : -111.17 (As of Dec. 14, 2024)

Pharmala Biotech Holdings EV-to-EBITDA Chart

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial							-12.09	-28.74	-26.76	-40.91	-76.74

Competitive Comparison of Pharmala Biotech Holdings's EV-to-EBITDA

For the Biotechnology subindustry, Pharmala Biotech Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmala Biotech Holdings's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmala Biotech Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmala Biotech Holdings's EV-to-EBITDA falls into.

Pharmala Biotech Holdings EV-to-EBITDA Calculation

Pharmala Biotech Holdings's EV-to-EBITDA for today is calculated as:

Pharmala Biotech Holdings's current Enterprise Value is $17.34 Mil.
Pharmala Biotech Holdings's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings  (OTCPK:MDXXF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Pharmala Biotech Holdings's PE Ratio (TTM) for today is calculated as:

Pharmala Biotech Holdings's share price for today is $0.19.
Pharmala Biotech Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Pharmala Biotech Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description